COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report

BACKGROUND: Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B virus (HBV) reactivation occurring in COVID-19 patients has not yet been reported. CASE S...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yi-Feng, Yu, Wan-Jun, Jiang, Yu-Hua, Chen, Yin, Zhang, Bo, Zhen, Rui-Bing, Zhang, Jun-Tao, Wang, Yi-Ping, Li, Qiang, Xu, Feng, Shi, Yan-Jun, Li, Xian-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283611/
https://www.ncbi.nlm.nih.gov/pubmed/34307577
http://dx.doi.org/10.12998/wjcc.v9.i19.5266
_version_ 1783723241929441280
author Wu, Yi-Feng
Yu, Wan-Jun
Jiang, Yu-Hua
Chen, Yin
Zhang, Bo
Zhen, Rui-Bing
Zhang, Jun-Tao
Wang, Yi-Ping
Li, Qiang
Xu, Feng
Shi, Yan-Jun
Li, Xian-Peng
author_facet Wu, Yi-Feng
Yu, Wan-Jun
Jiang, Yu-Hua
Chen, Yin
Zhang, Bo
Zhen, Rui-Bing
Zhang, Jun-Tao
Wang, Yi-Ping
Li, Qiang
Xu, Feng
Shi, Yan-Jun
Li, Xian-Peng
author_sort Wu, Yi-Feng
collection PubMed
description BACKGROUND: Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B virus (HBV) reactivation occurring in COVID-19 patients has not yet been reported. CASE SUMMARY: A 45-year-old hepatitis B man with long-term use of adefovir dipivoxil and entecavir for antiviral therapy had HBV reactivation after being treated with methylprednisolone for COVID-19 for 6 d. CONCLUSION: COVID-19 or treatment associated immunosuppression may trigger HBV reactivation.
format Online
Article
Text
id pubmed-8283611
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-82836112021-07-23 COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report Wu, Yi-Feng Yu, Wan-Jun Jiang, Yu-Hua Chen, Yin Zhang, Bo Zhen, Rui-Bing Zhang, Jun-Tao Wang, Yi-Ping Li, Qiang Xu, Feng Shi, Yan-Jun Li, Xian-Peng World J Clin Cases Case Report BACKGROUND: Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B virus (HBV) reactivation occurring in COVID-19 patients has not yet been reported. CASE SUMMARY: A 45-year-old hepatitis B man with long-term use of adefovir dipivoxil and entecavir for antiviral therapy had HBV reactivation after being treated with methylprednisolone for COVID-19 for 6 d. CONCLUSION: COVID-19 or treatment associated immunosuppression may trigger HBV reactivation. Baishideng Publishing Group Inc 2021-07-06 2021-07-06 /pmc/articles/PMC8283611/ /pubmed/34307577 http://dx.doi.org/10.12998/wjcc.v9.i19.5266 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Report
Wu, Yi-Feng
Yu, Wan-Jun
Jiang, Yu-Hua
Chen, Yin
Zhang, Bo
Zhen, Rui-Bing
Zhang, Jun-Tao
Wang, Yi-Ping
Li, Qiang
Xu, Feng
Shi, Yan-Jun
Li, Xian-Peng
COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
title COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
title_full COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
title_fullStr COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
title_full_unstemmed COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
title_short COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report
title_sort covid-19 or treatment associated immunosuppression may trigger hepatitis b virus reactivation: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283611/
https://www.ncbi.nlm.nih.gov/pubmed/34307577
http://dx.doi.org/10.12998/wjcc.v9.i19.5266
work_keys_str_mv AT wuyifeng covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT yuwanjun covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT jiangyuhua covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT chenyin covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT zhangbo covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT zhenruibing covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT zhangjuntao covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT wangyiping covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT liqiang covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT xufeng covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT shiyanjun covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport
AT lixianpeng covid19ortreatmentassociatedimmunosuppressionmaytriggerhepatitisbvirusreactivationacasereport

Ejemplares similares